Peptide sequence that promotes tumor invasion

Details Peptide sequence that promotes tumor invasion Peptide sequence that promotes tumor invasion

2006-11-14

2010-10-05

Yu, Misook (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S388100

Reexamination Certificate

active

07807790

ABSTRACT:
An isolated sequence SGSSEEKQNAVSSEET (OPNcPEP) SEQ ID NO: 8, and uses thereof. The peptide enhanced soft agar clone formation but did not support the growth of cells in plastic dishes, consistent with supporting anchorage-independence rather than growth. This sequence represented and is unique for a domain around the splice junction of OPN variant-c (OPN-c). OPN-c was expressed in a variety of tumor cell lines, but not in normal tissues (e.g., non-cancerous tissue) or in benign tumors. OPN-c antibody may be administered to a patient with a cancer associated with OPN-c expression to prevent the formation and growth of metastases. OPN-c may be used as a diagnostic to determine whether a patient has a malignant, rather than a benign, growth. OPN-c may be used to detect or identify agents that inhibit or mimic OPN-c expression or activity.

REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 2003/0087250 (2003-05-01), Monahan et al.
patent: 2003/0087270 (2003-05-01), Schlegel et al.
patent: 2003/0124128 (2003-07-01), Lillie et al.
patent: 2004/0142865 (2004-07-01), Weber
patent: 125023 (1984-11-01), None
patent: 171496 (1986-02-01), None
patent: 173494 (1986-03-01), None
patent: 184187 (1986-06-01), None
patent: 0 259 149 (1988-03-01), None
patent: 86/01533 (1986-03-01), None
patent: 87/02671 (1987-05-01), None
patent: 88/09810 (1988-12-01), None
patent: 89/10134 (1989-11-01), None
patent: 90/02809 (1990-03-01), None
patent: 91/17271 (1991-11-01), None
patent: 92/01047 (1992-01-01), None
patent: 92/09690 (1992-06-01), None
patent: 92/15679 (1992-09-01), None
patent: 92/18619 (1992-10-01), None
patent: 92/20791 (1992-11-01), None
patent: 93/01288 (1993-01-01), None
Roitt et al, Immunology, 1993, Mosby, St. Louis, Antibody Specificity p. 6.4-6.5.
Supplemental European Search Report and Opinion issued regarding concurrent European Patent Application No. 06837610.2 with references (Oct. 31, 2008).
He, et al., An Osteopontin Splice Variant Induces Anchorage Independent in Human Breast Cancer Cells. Oncogene (2006) 25, 2192-2202.
International Search Report issued regarding International Application No. PCT/US2006/044257 (May 16, 2007).
Written Opinion issued regarding International Application No. PCT/US2006/044257 (May 16, 2007).
International Search Report issued regarding International Application No. PCT/US2006/044257 (Sep. 10, 2007).
Written Opinion issued regarding International Application No. PCT/US2006/044257 (Sep. 10, 2007).
Mirza, et al., Osteopontin-c is a selective marker of breast cancer.Int. J. Cancer: 122,889-897 (2008).

Affiliated with

Also associated with

Rating

Peptide sequence that promotes tumor invasion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide sequence that promotes tumor invasion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide sequence that promotes tumor invasion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4169856